1. Home
  2. ASMB vs PAVS Comparison

ASMB vs PAVS Comparison

Compare ASMB & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • PAVS
  • Stock Information
  • Founded
  • ASMB 2005
  • PAVS 2004
  • Country
  • ASMB United States
  • PAVS United States
  • Employees
  • ASMB N/A
  • PAVS N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • PAVS Medicinal Chemicals and Botanical Products
  • Sector
  • ASMB Health Care
  • PAVS Health Care
  • Exchange
  • ASMB Nasdaq
  • PAVS Nasdaq
  • Market Cap
  • ASMB 84.5M
  • PAVS 90.2M
  • IPO Year
  • ASMB 2010
  • PAVS 2019
  • Fundamental
  • Price
  • ASMB $13.02
  • PAVS $1.38
  • Analyst Decision
  • ASMB Buy
  • PAVS
  • Analyst Count
  • ASMB 2
  • PAVS 0
  • Target Price
  • ASMB $35.00
  • PAVS N/A
  • AVG Volume (30 Days)
  • ASMB 20.5K
  • PAVS 9.8K
  • Earning Date
  • ASMB 03-27-2025
  • PAVS 01-01-0001
  • Dividend Yield
  • ASMB N/A
  • PAVS N/A
  • EPS Growth
  • ASMB N/A
  • PAVS N/A
  • EPS
  • ASMB N/A
  • PAVS N/A
  • Revenue
  • ASMB $28,326,000.00
  • PAVS $6,544,819.00
  • Revenue This Year
  • ASMB $282.16
  • PAVS N/A
  • Revenue Next Year
  • ASMB N/A
  • PAVS N/A
  • P/E Ratio
  • ASMB N/A
  • PAVS N/A
  • Revenue Growth
  • ASMB N/A
  • PAVS N/A
  • 52 Week Low
  • ASMB $11.03
  • PAVS $0.32
  • 52 Week High
  • ASMB $19.93
  • PAVS $2.49
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 40.89
  • PAVS 59.12
  • Support Level
  • ASMB $12.10
  • PAVS $1.32
  • Resistance Level
  • ASMB $14.25
  • PAVS $1.45
  • Average True Range (ATR)
  • ASMB 0.60
  • PAVS 0.06
  • MACD
  • ASMB -0.10
  • PAVS -0.01
  • Stochastic Oscillator
  • ASMB 35.11
  • PAVS 53.33

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.

Share on Social Networks: